FDA Approves Fingolimod Hydrochloride Application by Alembic
The FDA has granted approval for the ANDA207974 application for Fingolimod Hydrochloride submitted by Alembic.
Therapeutic Area
Therapeutic area intelligence for Multiple Sclerosis with 18 indexed intelligence signals across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
No related entities indexed yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.